Table 2

Comparisons of patients and controls with and without a previous non-vertebral fracture (mean (SD) for continuous variables, % for counts)

Patients with RAControls
Any fracture (53)No fracture (196)p ValueAny fracture (50)No fracture (199)p Value
For abbreviations, see table 1.
*For controls, disease duration  =  number of years since dummy time of disease onset, corresponding with the time of disease onset of the matched patient with RA.
p value, t tests for continuous and χ2 tests for dichotomous variables.
Demographic variables
Age (years)64.5 (6.2)62.6 (6.8)0.0665.1 (6.4)63.0 (6.7)0.04
Height163.0 (6.7)164.0 (5.8)0.28165.1 (6.1)163.4 (5.7)0.002
Weight67.7 (16.5)65.6 (11.2)0.0971.9 (11.2)69.0 (12.0)0.06
BMI (kg/m2)25.4 (5.8)24.2 (3.9)0.0826.4 (4.4)25.8 (4.1)0.13
Age at menopause (years)47.6 (8.0)48.8 (4.8)0.1649.8 (5.3)49.4 (4.8)0.38
Current smoker35.832.30.6522.031.60.20
Clinical variables
Disease duration*20.1 (10.8)15.6 (10.0)0.00420.7 (11.2)15.6 (10.0)0.002
Rheumatoid factor positive62.049.20.12
MHAQ1.8 (0.6)1.7 (0.5)0.191.1 (0.2)1.1 (0.3)0.60
DAS4.79 (1.33)4.68 (1.22)0.57
Any deformed joint77.459.20.02
Fracture before RA diagnosis13.29.20.3814.08.60.30
Long term CS use (⩾12 months)64.250.00.070.03.00.23
Current oestrogen use45.137.70.3718.032.10.05
Current bisphosphonate use21.69.70.0301.50.40
BMD variables
BMD femoral neck (g/cm2)0.76 (0.20)0.82 (0.13)0.020.88 (0.11)0.84 (0.13)0.03
BMD total hip (g/cm2)0.78 (0.19)0.85 (0.14)0.010.87 (0.13)0.92 (0.13)0.03
BMD L2–4 (g/cm2)1.00 (0.24)1.07 (0.19)0.031.05 (0.19)1.12 (0.19)0.03
Z score femoral neck−0.63 (1.00)−0.17 (1.35)0.01−0.19 (0.87)0.32 (0.98)0.03
Z score total hip−0.82 (1.24)−0.31 (1.05)0.01−0.10 (0.97)0.25 (0.98)0.03
Z score of the spine−0.11 (1.90)0.36 (1.44)0.050.16 (1.48)0.68 (1.53)0.03